Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000255556 encodes a pseudogene sequence related to ubiquitin specific peptidase 17-like 2. Pseudogenes are segments of DNA that are similar to known genes but are nonfunctional, generally due to mutations that disable their protein-coding capacity. While a small number of pseudogenes can be transcribed or exert regulatory RNA effects, the majority, including this one, are considered genomic fossils with no direct function. Pseudogenes do not encode receptors, enzymes, or drug targets, and are not generally used in therapeutic, diagnostic, or prognostic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17-like 2 pseudogene.